Vimarsana
Biggest News Aggregation in the World

Page 7 - Webcast Today News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Webcast Today. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Webcast Today Today - Breaking & Trending Today

Perimeter Medical Imaging AI Reports 2022 Financial Results and Provides Corporate Update - Vimarsana News

Perimeter Medical Imaging AI Reports 2022 Financial Results and Provides Corporate Update

Conference Call/Webcast Today at 5 pm ET TORONTO and DALLAS, April 11, 2023 /CNW/ - Perimeter Medical Imaging AI, Inc. – a medical technology company driven to transform cancer surgery with... | April 11, 2023

Cytokinetics Announces COURAGE-ALS Met Criteria for Futility at Second Interim Analysis - Vimarsana News

Cytokinetics Announces COURAGE-ALS Met Criteria for Futility at Second Interim Analysis

Company Plans to Discontinue the Phase 3 Clinical Trial of Reldesemtiv After Data Monitoring Committee Found No Effect on Primary or Key Secondary Endpoints Cytokinetics to Host Conference Call and... | March 31, 2023

HUTCHMED (China) Limited: HUTCHMED Reports 2022 Full Year Results and Provides Business Updates - Vimarsana News

HUTCHMED (China) Limited: HUTCHMED Reports 2022 Full Year Results and Provides Business Updates

Landmark licensing deal with Takeda for fruquintinib outside of China, bringing HUTCHMED up to US$1.13 billion, plus royalties, and demonstrating execution of the new global strategy Record Full Year

Mallinckrodt plc Reports Fourth Quarter and Fiscal 2022 Financial Results and Provides 2023 Guidance - Vimarsana News

Mallinckrodt plc Reports Fourth Quarter and Fiscal 2022 Financial Results and Provides 2023 Guidance

/PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today reported results for...

Exelixis Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update - Vimarsana News

Exelixis Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

- Total Revenues of $423.9 million for the Fourth Quarter of 2022, $1.61 billion for the Full Year 2022 -- Cabozantinib franchise achieved $1.40 billion in U.S. Net Product Revenues for the Full Year 2022, including $377.4 million for the Fourth Quarter 2022 -- GAAP Diluted EPS of $(0.09) for the Fourth Quarter of 2...